Welcome Message

Dear Colleagues,

We are delighted to welcome you to the 5th International Breast Cancer Symposium, taking place from September 25–26, 2026, at the Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.

Building on the success of last year’s symposium—which brought together leading voices in breast cancer care for an inspiring exchange of knowledge and collaboration—we return this year with even greater ambition and purpose. This year’s program offers a compelling and thoughtfully curated scientific agenda, highlighting key areas shaping the future of breast oncology, including Early Breast Cancer, the evolving role of Antibody-Drug Conjugates (ADC), HER2-positive disease, modern surgical management, as well as survivorship, lobular disease, and research collaboration.

Through a series of expert-led sessions, the symposium will explore the latest treatment approaches driven by recent drug approvals and pivotal clinical trials, alongside cutting edge innovations such as carbon ion therapy and progressive strategies for surgical deescalation in selected patients—reflecting the rapid advancement of our field.